Patents by Inventor Yasuteru SAKURAI

Yasuteru SAKURAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)
    Publication number: 20230190690
    Abstract: The present invention provides a therapeutic and/or preventive agent for coronavirus disease 2019 (COVID-19) comprising 5-aminolevulinic acid (ALA) or its derivative or a salt thereof and provides a method for treating and/or preventing coronavirus disease 2019 (COVID-19) using the therapeutic and/or preventive agent.
    Type: Application
    Filed: April 22, 2021
    Publication date: June 22, 2023
    Applicants: NEOPHARMA JAPAN CO., LTD., NAGASAKI UNIVERSITY
    Inventors: Kiyoshi KITA, Kouichi MORITA, Jiro YASUDA, Yasuteru SAKURAI, Satofumi KAWATA, Tohru TANAKA, Motoyasu TOMIOKA, Kiyotaka FUJINE
  • PROPHYLACTIC OR THERAPEUTIC AGENT FOR RNA VIRUS-RELATED DISEASES
    Publication number: 20230147364
    Abstract: A a prophylactic or therapeutic agent for RNA virus-related diseases is provided, the prophylactic or therapeutic agent containing, as an active ingredient, at least one compound selected from the group consisting of a selective estrogen receptor modulator, an anti-tuberculosis drug, a CysLT1 receptor antagonist, a peroxisome proliferator-activated receptor ? (PPAR?) agonist, an arachidonate 5-lipoxygenase (5-LOX) inhibitor, a derivative thereof, a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable solvate thereof.
    Type: Application
    Filed: April 28, 2021
    Publication date: May 11, 2023
    Inventors: Haruhisa INOUE, Keiko IMAMURA, Jiro YASUDA, Yasuteru SAKURAI
  • Amodiaquine analogs and methods of uses thereof
    Patent number: 11571416
    Abstract: Described herein are pharmaceutical compositions capable of blocking entry of a virus into a host cell and containing one or more compounds of the general formula I or a pharmaceutically acceptable derivative thereof and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat viral infections.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: February 7, 2023
    Assignee: Kagoshima University
    Inventors: Robert A. Davey, Yasuteru Sakurai, Masanori Baba, Norikazu Sakakibara
  • NOVEL AMODIAQUINE ANALOGS AND METHODS OF USES THEREOF
    Publication number: 20200113891
    Abstract: Described herein are pharmaceutical compositions capable of blocking entry of a virus into a host cell and containing one or more compounds of the general formula I or a pharmaceutically acceptable derivative thereof and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat viral infections.
    Type: Application
    Filed: April 13, 2018
    Publication date: April 16, 2020
    Inventors: Robert A. DAVEY, Yasuteru SAKURAI, Masanori BABA, Norikazu SAKAKIBARA